These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3104865)

  • 1. Effect of protective and non-protective antibodies in the phagocytosis rate of Trypanosoma cruzi blood forms by mouse peritoneal macrophages.
    Lages-Silva E; Ramirez LE; Krettli AU; Brener Z
    Parasite Immunol; 1987 Jan; 9(1):21-30. PubMed ID: 3104865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies.
    Lima-Martins MV; Sanchez GA; Krettli AU; Brener Z
    Parasite Immunol; 1985 Jul; 7(4):367-76. PubMed ID: 3929211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
    Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
    Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease.
    Cordeiro FD; Martins-Filho OA; Da Costa Rocha MO; Adad SJ; Corrêa-Oliveira R; Romanha AJ
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):112-8. PubMed ID: 11139203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytosis of the three developmental forms of Trypanosoma cruzi: effect of specific sera.
    Villalta F; Oda LM; Angluster J; Alviano CS; Leon W
    Acta Trop; 1981 Dec; 38(4):375-81. PubMed ID: 6123245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: isolate dependence in the induction of lytic antibodies in the mouse and rabbit.
    Muller LA; Añasco N; González Cappa SM
    Exp Parasitol; 1986 Jun; 61(3):284-93. PubMed ID: 3086113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.
    Krettli AU; Brener Z
    J Immunol; 1982 May; 128(5):2009-12. PubMed ID: 6801127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.
    Gazzinelli RT; Galvão LM; Cardoso JE; Cançado JR; Krettli AU; Brener Z; Gazzinelli G
    J Clin Microbiol; 1988 Sep; 26(9):1795-800. PubMed ID: 3141467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface interactions between macrophages and Trypanosoma cruzi.
    Reed SG; Douglass TG; Speer CA
    Am J Trop Med Hyg; 1982 Jul; 31(4):723-9. PubMed ID: 7048947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
    Umekita LF; Ramos DP; Barbaro KC; Mota I
    Immunol Lett; 1999 Nov; 70(2):73-6. PubMed ID: 10569694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.
    Yoshida N
    Exp Parasitol; 1986 Apr; 61(2):184-91. PubMed ID: 3082663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.
    Brener Z; Gazzinelli RT
    Int Arch Allergy Immunol; 1997 Oct; 114(2):103-10. PubMed ID: 9338602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
    Almeida IC; Milani SR; Gorin PA; Travassos LR
    J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of insect-borne, metacyclic forms of Trypanosoma cruzi to antibody-mediated mechanisms of destruction.
    Kierszenbaum F; Lima MF
    Am J Trop Med Hyg; 1983 Nov; 32(6):1236-41. PubMed ID: 6418013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.
    Budzko DB; Pizzimenti MC; Kierszenbaum F
    Infect Immun; 1975 Jan; 11(1):86-91. PubMed ID: 46840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.